“The Warmth of His Continuing Interest”: Henry K. Beecher, the Bioethics Revolution, and Pharmaceutical Industry Funding of Academic Medical Science in Cold War America
- 2 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the History of Medicine and Allied Sciences
- Vol. 78 (2), 191-208
- https://doi.org/10.1093/jhmas/jrad011
Abstract
This paper examines anesthesiologist Henry K. Beecher’s funding relationship with pharmaceutical manufacturer Edward Mallinckrodt, Jr. Beecher is a familiar figure to both medical ethicists and historians of medicine for his role in the bioethics revolution of the 1960s and 1970s. In particular, his 1966 article “Ethics and Clinical Research” is widely considered a turning point in the post-World War II debate about informed consent. We argue that Beecher’s scientific interests should be understood in the context of his funding relationship with Mallinckrodt and that this relationship shaped the direction of his work in important ways. We also argue that Beecher’s views on research ethics reflected his assumption that collaboration with industry was a normal part of how academic science is conducted. In the conclusion of the paper we suggest that Beecher’s failure to consider his relationship with Mallinckrodt as worthy of ethical deliberation has important lessons for academic researchers who collaborate with industry today.Keywords
This publication has 19 references indexed in Scilit:
- “Ethics and Clinical Research” — The 50th Anniversary of Beecher’s BombshellThe New England Journal of Medicine, 2016
- The Origin of the Medical Research Grant in the United States: The Rockefeller Foundation and the NIH Extramural Funding ProgramJournal of the History of Medicine and Allied Sciences, 2014
- The Testing of Sanocrysin: Science, Profit, and Innovation in Clinical Trial Design, 1926-31Journal of the History of Medicine and Allied Sciences, 2013
- Industry Sponsorship and Research OutcomeJAMA Internal Medicine, 2013
- Reform, Regulation, and Pharmaceuticals — The Kefauver–Harris Amendments at 50The New England Journal of Medicine, 2012
- Academic–Industrial Relations Before the Blockbuster Drugs: Lessons From the Harvard Committee on Pharmacotherapy, 1939–1943Academic Medicine, 2011
- Academic collaboration and organizational innovation: the development of research capabilities in the US pharmaceutical industry, 1927-1946Industrial and Corporate Change, 2009
- ‘Patenting in the public interest:’ administration of insulin patents by the University of TorontoHistory and Technology, 2008
- Science in Dachau's shadow: HEBB, Beecher, and the development of CIA psychological torture and modern medical ethicsJournal of the History of the Behavioral Sciences, 2007
- Recruiting Allies for ReformInternational Anesthesiology Clinics, 2007